These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Measuring the relationship of quality of life and health status, including tumor burden, symptoms, and biochemical measures in patients with neuroendocrine tumors. Vinik E, Silva MP, Vinik AI. Endocrinol Metab Clin North Am; 2011 Mar; 40(1):97-109, viii. PubMed ID: 21349413 [Abstract] [Full Text] [Related]
16. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts. Kim JY, Hong SM. Arch Pathol Lab Med; 2016 May 25; 140(5):437-48. PubMed ID: 27128301 [Abstract] [Full Text] [Related]
17. [Incidence, pathology and clinical course and symptoms of neuroendocrine gastrointestinal tumours]. Federspiel BH, Hansen CP, Vainer B, Hasselby JP, Bardram L, Knigge U. Ugeskr Laeger; 2010 Oct 25; 172(43):2946-50. PubMed ID: 21040672 [Abstract] [Full Text] [Related]
20. Foreword: Gastroenteropancreatic system and its tumors: Part 2. LeRoith D. Endocrinol Metab Clin North Am; 2011 Mar 25; 40(1):xiii-xv. PubMed ID: 21349407 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]